SBIR PHASE II, TOPIC 019: ELECTROSPUN BIODEGRADABLE MEMBRANE INSERTS

SBIR 第二阶段,主题 019:电纺生物可降解膜插入物

基本信息

  • 批准号:
    10505601
  • 负责人:
  • 金额:
    $ 197.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-24 至 2023-09-23
  • 项目状态:
    已结题

项目摘要

Cell culture tools expand our abilities to conduct research from studying basic properties to developing specific medical treatments. These tools work best when they mimic cell’s and tissue's biological environment as closely as possible while maintaining high reproducibility in high throughput in vitro assays. As such, cell culture is moving to 3D tissue models, focusing on their in vivo-like properties as opposed to earlier 2D culture. Biodegradable nanofiber membranes offer an advance for in vitro tissue modeling: they contain biomimetic ECM topography, which provides temporary structural support and relevant mechanical and spatial growth cues for nascent tissues. The proposed cell culture biodegradable insert membrane will provide early biomimetic support for seeded cells; cellular extracellular matrix will then replace the function of the membrane as is degrades, resulting in free-standing tissue attached to the insert, for experimentation. To this end, biodegradable membranes will be incorporated into a novel cell culture insert for 96-well plates. Electrospinning will be used to create the nanofibrillar membranes composed of PCL and PLGA, two well characterized biodegradable biomaterials. Two designs will be investigated initially with monoculture cell sheets, and then subsequently, in the Phase I neuronal co-culture model to validate the insert. The insert is required to have specific dimensions, be compatible with imaging techniques used by most researchers, and to have specific pore size and degradation kinetics to mimic integration into the body.
细胞培养工具扩展了我们进行研究的能力,从研究基本特性到开发特定的医学治疗。当这些工具尽可能接近地模拟细胞和组织的生物环境,同时在高通量体外分析中保持高再现性时,这些工具的效果最好。因此,细胞培养正在转向3D组织模型,专注于它们在体内的类似特性,而不是早期的2D培养。可生物降解的纳米纤维膜为体外组织建模提供了一个进步:它们包含仿生ECM地形,为新生组织提供临时的结构支持和相关的机械和空间生长线索。提出的细胞培养生物可降解插入膜将为种子细胞提供早期仿生支持;细胞外基质将在降解时取代膜的功能,从而形成附着在插入物上的独立组织,用于实验。为此,生物可降解膜将被纳入一个新的细胞培养插入96孔板。静电纺丝将用于制备由PCL和PLGA这两种具有良好表征的可生物降解生物材料组成的纳米纤维膜。两种设计将首先用单培养细胞片进行研究,然后在第一阶段的神经元共培养模型中验证插入物。插入物需要具有特定的尺寸,与大多数研究人员使用的成像技术兼容,并且具有特定的孔径和降解动力学,以模拟与体内的整合。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KRISTIN TATON其他文献

KRISTIN TATON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 197.22万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 197.22万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 197.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 197.22万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 197.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 197.22万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 197.22万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 197.22万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 197.22万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 197.22万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了